In this analysis, researchers evaluated whether beta blocker use is associated with improved survival in patients with solid tumors.

In this study, researchers aimed to characterize the relationship between major depressive disorder, use of antidepressants, and risk of recurrence in breast cancer patients.

Investigators assessed differences in efficacy and toxicity of first-line chemotherapy with and without targeted in therapy ...

The US Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer. The agency sent a warning letter ...

Patients reported feeling comfortable interacting with care team remotely and felt emotionally supported by care team ...

Lirafugratinib, an oral FGFR2 inhibitor, receives FDA Priority Review for advanced cholangiocarcinoma with FGFR2 rearrangements or fusions.

It has had 3 different leaders during the current Trump administration and on Wednesday, the White House missed its deadline for nominating a candidate. Federal law limits someone to serve in an ...

An evolving understanding of the risks and benefits of HRT has led to a reevaluation of the role of HRT for breast cancer survivors.

Investigators compared mortality risk among long-term survivors of high-grade serous ovarian cancer versus the general US population to examine how mortality and recurrence trends have changed with ...

Investigators examined age-standardized cancer mortality rates by “urbanicity” of county of residence to determine whether trends in mortality shifted from 1969 to 2023.

Investigators expanded on previous results from the DEAR study, comparing darolutamide versus enzalutamide and apalutamide ...

Investigators sought to increase HPV vaccination rates in children by age 13 years through the use of a multicomponent strategy in pediatric primary care practices.